Clinical Trial Update: Apatinib in Neoadjuvant Therapy for Patients With Breast Cancer [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for apatinib in neoadjuvant therapy for breast cancer (Phase 2/Phase 3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Hebei Medical University Fourth Hospital | Conditions: Breast Cancer | Phase 2, Phase 3 | Status: UNKNOWN